Two studies focus on glaucoma medication adherence

May 15th, 2014

Electronic monitoring to measure medication adherence by patients with glaucoma documented that a sizable number of patients did not regularly use the eye drops prescribed to them.

Topical medications for glaucoma lower intraocular pressure and can delay or slow the progression of the eye disease. Medication adherence is important.

Patients who were treated with once-daily prostaglandin eye drops were recruited from a university-based glaucoma clinic. Patients were given a container with an electronic cap in which to store their eye drops. The cap recorded each time the container was opened.

Of the 407 patients who completed the three-month adherence assessment, 337 (82.8 percent) took their medication correctly on at least 75 percent of days. The other 70 patients (17.2 percent) (deemed nonadherent) were less likely to be able to name their glaucoma medication, less likely to agree that remembering to use the medication was easy, and more likely to agree with the sentiment that eye drops can cause problems.

"Given that most patients are taking their eye drops as prescribed, identifying patients at risk of nonadherence is a critical step. The results from the patient questions and demographic factors may therefore be useful in creating risk calculators that could find those patients most in need of intervention."

(JAMA Ophthalmol. Published online May 15, 2014. doi:10.1001/.jamaopthalmol.2014.856. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: This study was supported by a grant from the Microsoft Be Well Fund. Please see article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

An intervention that included text or voice messages appeared to help patients with glaucoma adhere to their eye drop medication.

The barriers to medication adherence by patients with glaucoma are complex. There is a growing body of work on improving adherence.

The 70 nonadherent patients in the related study that assessed medication adherence were randomized to an intervention (n=38) or to a control group (n=32) where they received no additional intervention. The intervention consisted of daily messages, either text or voice, reminding patients to use their glaucoma medication. A personal health record was used to store lists of patient medications and reminder preferences.

The median adherence rate in the 38 patients in the intervention increased from 53 percent to 64 percent. There was no change in the control group. Patients in the intervention (84 percent) agreed the reminders were helpful and that they would continue to use them outside the study. Implementing the intervention is estimated to cost about $20 per year per patient.

"We found that a telecommunication-based reminder linked to a personal health record can increase adherence with once-daily glaucoma medications. This finding is important because it supports an intervention that is feasible in terms of time and cost for a typical ophthalmology practice."

(JAMA Ophthalmol. Published online May 15, 2014. doi:10.1001/.jamaopthalmol.2014.857. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: This study was supported by a grant from the Microsoft Be Well Fund. Please see article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Provided by The JAMA Network Journals

This Phys.org Science News Wire page contains a press release issued
by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.

More news stories

In the bid to come up with authentication solutions beyond passwords, fingerprint authentication from Qualcomm is making news, and so is Fujitsu's iris recognition, yet another potential authentication tech ...

UCLA life scientists have created an accurate new method to identify genetic markers for many diseases—a significant step toward a new era of personalized medicine, tailored to each person's DNA and RNA.

Recent concussion laws that set out to prevent head injuries in American teenage athletes should be extended to include the activities of summer camps, travel teams and all-star teams. This will ensure that all children and ...

A new study by the University of Texas Medical Branch found that 20 percent of men were prescribed testosterone despite having normal testosterone levels based on the Endocrine Society's guidelines. The study ...

Drug-induced acute liver failure is uncommon, and over-the-counter medications and dietary and herbal supplements—not prescription drugs—are its most common causes, according to new research from the Perelman School of ...

The American Thoracic Society has published the results of a survey of the ATS membership on climate change which found that the majority of ATS members believe that climate change is real and that it is having a negative ...

Javascript is currently disabled in your web browser. For full site functionality, it is necessary to enable Javascript.
In order to enable it, please see these instructions.